TY - DATA T1 - Additional file 2: Figure S1. of Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate PY - 2017/01/05 AU - Wenqi Zheng AU - Fei Liu AU - Yiwen He AU - Qingyang Liu AU - Gregory Humphreys AU - Takafumi Tsuboi AU - Qi Fan AU - Enjie Luo AU - Yaming Cao AU - Liwang Cui UR - https://springernature.figshare.com/articles/dataset/Additional_file_2_Figure_S1_of_Functional_characterization_of_Plasmodium_berghei_PSOP25_during_ookinete_development_and_as_a_malaria_transmission-blocking_vaccine_candidate/4523039 DO - 10.6084/m9.figshare.c.3658814_D2.v1 L4 - https://ndownloader.figshare.com/files/7319153 KW - Plasmodium berghei KW - PSOP25 KW - Ookinete KW - Transmission-blocking vaccine N2 - Predicted B cell epitopes of the PSOP25 protein ( http://tools.iedb.org/bcell ). Below is the protein domain architecture of PSOP25 with signal peptide highlighted in red, low complexity in pink, and transmembrane region in blue. Figure S2. The isotype of anti-rPSOP25 mAb was identified by ELISA using by the SBA Clonotyping™ System-HRP. The data represent two separate experiments. Error bar shows mean + standard deviation. Figure S3. Western blot analysis of P. berghei ookinete lysates with anti-rPSOP25 sera (PolyAb) and anti-rPSOP25 mAb. Lysates were subjected to electrophoresis under non-reducing conditions by SDS-PAGE. Pbs21 mAb was used as positive control; a control mouse serum (PBS) was used as negative control. (ZIP 2413 kb) ER -